Feed

Show only
27 Mar 20
Corona Up­date
Corona Up­date Em­ploy­ers:
31 Mar 20
In­tern­al in­vest­ig­a­tions in HR cases – best prac­tices
Em­ploy­ment we­bin­ar series
27 Mar 20
Man­aging clin­ic­al tri­als un­der COV­ID-19: New EU guid­ance is­sued for...
The COV­ID-19 pan­dem­ic has had a dra­mat­ic im­pact on European health sys­tems, whose pri­or­ity first and fore­most is the treat­ment of pa­tients suf­fer­ing from this dis­ease both in the in-pa­tient and out-pa­tient...
CMS Ex­pert Guide to Com­pet­i­tion Law Dur­ing Coronavir­us...
31 Mar 20
Cov­id-19 (coronavir­us) Em­ploy­ment We­bin­ar
What now and what after
26 Mar 20
ESMA and FCA is­sue state­ments con­cern­ing reg­u­lat­ory for­bear­ance for...
Cor­rect as of 12pm on 23 March. This art­icle is not be­ing main­tained. On 18 March 2020, the European Se­cur­it­ies and Mar­kets Au­thor­ity (“ESMA”) pub­lished a state­ment about  reg­u­lat­ory for­bear­ance...
CMS Ex­pert Guide to Force Ma­jeure
02 Apr 20
Cov­id-19 (Coronavir­us) – Key Com­mer­cial Con­sid­er­a­tions
26 Mar 20
European Com­mis­sion pro­poses delay­ing the May 2020 ap­plic­a­tion of...
The European Com­mis­sion has con­firmed it is work­ing on a pro­pos­al to delay for one year the date of ap­plic­a­tion of the new EU Med­ic­al Devices Reg­u­la­tion 2017/745/EU (the “MDR”) in light of the Cov­id-19...
CMS Ex­pert Guide to Sta­bil­isa­tion and Re­struc­tur­ing...
13 May 20
Private Equity Break­fast
26 Mar 20
Do­ing ar­bit­ra­tion dif­fer­ently: doc­u­ments-only ar­bit­ra­tion dur­ing the...
The dis­rup­tion caused by the COV­ID-19 pan­dem­ic has left com­pan­ies across the world scram­bling to main­tain a sense of con­tinu­ity, as their ex­ec­ut­ives, em­ploy­ees and ad­visers ad­just to life un­der gov­ern­ment-im­posed...